It’s no secret, your body goes through some major changes during pregnancy. A lesser known fact is some expecting women experience vision changes pre-and post-partum.
How come my vision changed after I had a baby?
Approximately 20 percent of women experience this, according to Arian Fartash, OD. “The reason is because a lot of hormone changes go on when you’re pregnant.”
Hormones play a significant role in fluid retention so when estrogen levels are elevated, women tend to retain more water than usual. Just as many women will experience swollen feet, your eyes can swell too which could cause vision changes. The fluid retention can change the shape of the cornea which changes the way light passes through the eye, distorting one’s vision.
“It starts at the beginning of pregnancy, when your hormones are going all over the place,” said Dr. Fartash.
Your vision may return to normal once the hormones level out, but you could also experience the change permanently.
Dr. Fartash explains what you should do if you notice vision changes when you’re expecting in this episode of #AskAnEyeDoc:
Whether you’re pregnant or not, you should consult with your eye doctor if you notice any changes in your vision. Don’t have an eye doctor? Use our Find a Doctor tool for a quick and easy way to locate your nearest VSP network provider.
Need a vision care plan? Check out all the available individual plans to meet your eye care needs.
If you have a general eye-related question, be sure to comment below or post to social media with hashtag #AskAnEyeDoc.
Disclaimer: Information received through VSP Vision Care’s social media channels is for informational purposes only and does not constitute medical advice, medical recommendations, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Editas Medicine , a company developing gene-editing treatments, has received authorization from the US Food and Drug Administration to launch a clinical trial for its emerging CRISPR/Cas9 therapy for people with a mutation in the gene CEP290, which causes Leber congenital amaurosis 10 (LCA10). LCA causes severe vision loss or blindness at birth. Known as EDIT-101, the treatment will be evaluated in a Phase 1/2, dose-escalation clinical trial. The company expects to enroll 10 to 20 patients. Further details and contact information for the study will be listed soon at www.clinicaltrials.gov . EDIT-101 targets a specific mutation, “c.2991+1655A>G” in intron 26, of the CEP290 gene. Editas has earned a $25 million milestone payment from Allergan as part of a drug-development alliance. “We are very pleased with this historic milestone in the treatment of inherited retinal diseases,” says Stephen Rose, PhD, chief scientific officer, Foundation Fighting Blindness. “EDIT-101 is the fi...
Written by Dr. David Evans Last modified on September 6, 2018 An article I wrote back in April described a National Bureau of Economic Research study that concluded cataract surgery patients have a life expectancy 1.8 years longer than people with cataracts who do not undergo surgery. Much of that piece focused on the finding that people, who have vision diminished by cataracts, are less likely to be active, and more likely to suffer accidental falls and related injuries. As a follow-on, a new study published in JAMA Ophthalmology suggests an even stronger link between cataract surgery and mortality risk. About the Study The genesis of this study was something completely different than evaluating effects of cataract vision loss. Its original purpose was to evaluate the effects of hormone therapy and dietary changes in postmenopausal women. That study was cut short once it was determined that hormone therapy increased the risk of vascular events. Although the hormone therapy aspect ...
APR 20, 2018 By Anni Griswold Cornea/External Disease, Glaucoma, Retina/Vitreous A weekly roundup of ophthalmic news from around the web. An Instagram model paid the ultimate price to change her eye color from hazel to light grey. Nadinne Bruna, 32, shelled out $3,000 to have silicone plates implanted in front of her iris, but the procedure ended up costing her much more: 80% of vision in her right eye and 50% in her left eye. Daily Mail Glaucoma expert Thomas W. Samuelson, MD, took the reins this month as the 33 rd president of the American Society of Cataract and Refractive Surgery (ASCRS). Samuelson is an attending surgeon and founding partner of Minnesota Eye Consultants, and an adjunct professor of ophthalmology at the University of Minnesota. Healio Canadian engineer Marinko Sarunic says his shoebox-sized retinal scanner (shown above) can capture high-resolution, 3-D, cross-sectional images of the tissue in a level of detail that rivals images from much larger s...
Comments
Post a Comment